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ENGRAFTMENT AND IMMUNOLOGIC RECOVERY IN SIX ADULT PA-
TIENTS TREATED WITH BUCYT AND HUMAN UMBILICAL CORD STEM
CELL TRANSPLANTATION
Janakiraman, N., Nath, R., Chamarthy, U., Vial, I., Fortney, C., Ray,
K. Henry Ford Health System, Detroit, MI.
Between 6/2000 and 6/2003 six adult patients, age 26-58, re-
ceived BuCyT followed by umbilical cord stem cell transplant for
various diagnoses. AML  2, ALL  1, CLL  1, myeloma  1,
and SAA  1. All except one patient received 1 or 2 antigen
mismatched stem cells. They received a median of 2.18 x 10 x 7
TNC/kg (range 1.48-3.12) and CD34  1.5 x 10 x 5/kg (range
0.4-4.2). Median time to ANC 500 was 26 days (range 15-46) and
platelet 20,000 was 66 days (range 42-191). At 1 year, median CD4
count was 357 in 4 patients (range 264-715) and IgG level was 840
mg/dl (range 820-1640). All six patients had 100% donor engraft-
ment documented by STR analysis as early as 1-2 months. Overall
Grade III Acute GVHD was seen in 3 patients (2 skin and 1 gut).
No Grade IV GVHD was seen. Limited chronic GVHD involving
the skin and mucosa was seen in 4 patients. Two patients had
recurrent CMV reactivation and in one of them it contributed to
delayed platelet engraftment. One patient had bacterial meningitis
caused by Flavobacterium Meningo Septicum and 1 patient had
aspergillus sinusitis. With a median followup of 18 months (4-40
months), all 6 patients are alive and in remission/stable disease. In
summary, umbilical cord stem cell transplant is an alternate source
of stem cells for patients without matched sibling donors. Though
the platelet engraftment may be delayed, the transplant related
morbidity is small in this small group of poor risk patients.
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SIGNIFICANT DECREASED LIPOPOLYSACCHARIDE (LPS)-ACTIVATED
CYTOKINE/RECEPTOR, CHEMOKINE, IMMUNOREGULATORY, TRAN-
SCRIPTION, APOPTOTIC, SIGNALING AND CELL STRUCTURE GENE
EXPRESSION IN CORD BLOOD (CB) COMPARED TO ADULT PERIPH-
ERAL BLOOD (APB) MONOCYTES BY OLIGONUCLEOTIDE GENE EX-
PRESSION MICROARRAY: INSIGHT INTO DIFFERENTIAL APB VERSUS
CB MONOCYTE STRUCTURE AND FUNCTION
Jiang, H., van de Ven, C., Satwani, P., Baxi, L., Cairo, M.S. Children’s
Hospital of New York-Presbyterian, Columbia University, New York,
NY.
Umbilical cord blood hematopoiesis and cellular immunity are
developmentally immature when compared with adult peripheral
blood (Cairo et al, Blood 90:4465,1997). We and others have
demonstrated that umbilical cord blood transplantation (UCBT)
is associated with decreased (grade III-IV) aGVHD, but de-
layed immune reconstitution (Abu-Ghosh/Cairo et al, BMT 24:
535,1999). Recently, the contribution of allograft monocytes to the
induction of GVHD and/or immune tolerance has been demon-
strated (Aranha et al, Haematologica, 87:219, 2002). Monocytes
are critically important in the generation of cytokines, chemokines,
immune mediators and the initiation of the cellular immune re-
sponses. We and others have previously demonstrated signiﬁcant
dysregulated cytokine gene expression and protein production and
in vitro functional activities of activated CB versus APB MNC. In
this study we compared, by oligonucleotide microarray, the differ-
ential gene expression proﬁles of basal and LPS-activated APB
versus CB monocytes. Brieﬂy, Mo were puriﬁed from fresh CB or
APB (N  5) and stimulated with LPS (10 g/ml, 18 hours).
mRNA was isolated, reverse transcripted to cDNA, labeled and
hybridized to oligonucleotides (Affymetrix, U95A) (Huang et al,
Science 294:870, 2001). Data was analyzed by Microarray Suite
Version 5.0 (Affymetrix) and hierarchical clustering analysis was
performed by GeneSpring 5.0 software (Silicon Genetics). Quan-
titative real time PCR (LightCycler-RNA ampliﬁcation SYBR
Green I kit, Roche Molecular Biochemicals) was used to examine
selected genes to conﬁrm expression levels. We demonstrated
patterns of signiﬁcant differential ampliﬁed gene expression in
LPS-activated APB versus CB monocytes including cytokine (G-
CSF, 14 fold), chemokine (MIP-1, 5 fold), immunoregulatory
(MHC DRB1, 5 fold), transcription factor (JunB, 4 fold), signal
transduction (STAT4, 5 fold), apoptotic regulation (BAX, 5 fold)
and cell structure (ladinin 1, 6 fold) among others. These results
suggest that some of these differentially expressed genes may in
part be responsible for the differences in the incidence and severity
of aGVHD, immunoreconstitution and/or the ability to cross more
disparate HLA barriers following UCBT. Moreover, these data
provide insight into the molecular basis for differential cellular
function and immune responses between activated CB and APB
monocytes.
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EXAMINING CYTOTOXIC EFFECTS ON THYMIC RECONSTITUTION: A
MODEL
Prockop, S.E., O’Reilly, R.J., Petrie, H.T. Memorial Sloan Kettering
Cancer Center, New York, NY.
A key component of long-term outcome after BMT is successful
reconstitution of the immune system. Effective reconstitution of
antigen-speciﬁc immunity requires de novo T cell generation.
Bone marrow derived progenitors seed the thymus and undergo a
complex process involving lineage commitment, proliferation and
selection. This process requires coordinated interaction of mar-
row-derived lymphoid progenitors with thymic stromal cells. Dis-
ruption of the microenvironment can result in disrupted T cell
lymphopoiesis. One cause of prolonged defects in generating func-
tional T cells after BMT is damage to the thymic microenviron-
ment. However, the impact of individual agents, administered at
myeloablative or non-myeloablative doses, on the thymic micro-
environment has not been fully evaluated. In addition, mechanisms
by which stromal injury modiﬁes T cell production and maturation
have only begun to be understood. We have developed a model
system using immunodeﬁcient mice as a platform on which to
assess thymic reconstitution. The thymus of mice deﬁcient for the
alpha chain of the IL-7 receptor (IL7R
/
) is relatively depleted
of lymphoid cells and can be reconstituted following transplant of
wild type marrow without prior myeloablative or immunosuppres-
sive treatment. Injection of low doses of wild type bone marrow
into these mice results in a normally cellular thymus repopulated
with donor derived lymphocytes. The ability to achieve this recon-
stitution appears to depend on absolute numbers of early intra-
thymic precursors, rather than on total thymic cellularity. Our
model system allows the evaluation of thymic reconstitution after
single agent regimens insufﬁcient to allow donor cell engraftment
in wild type mice. We have exploited it to differentially assess the
effects of cytotoxic agents including radiation and immunosuppres-
sive drugs, on the capacity of the thymic microenvironment to
support the maturation of normal lympoid progenitors. The effects
of several agents on thymic reconstitution will be presented. For
example, after low dose TBI (350rads), reconstitution is preserved,
while after high dose (900rads)TBI it is not. It is anticipated that
this information will lead to strategies to minimize delayed im-
mune reconstitution and to augment T cell lymphopoiesis post-
transplant. In addition, further evaluation of impaired thymic re-
constitution will augment the understanding of lymphostromal
interactions crucial to normal T cell lymphopoiesis.
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IMMUNE RECONSTITUTION AFTER ALLOGENEIC BONE MARROW
TRANSPLANTATION INVOLVES PERIPHERAL T CELL APOPTOSIS
Alpdogan, O.1, McGoldrick, S.1, Budak-Alpdogan, T.2, Hubbard,
V.M.1, Eng, J.M.1, Muriglan, S.J.1, Kochman, A.1, van den Brink,
M.R.M.1 1. Memorial-Sloan Kettering Cancer Center, New York, NY;
2. The Cancer Institute of New Jersey, New Brunswick, NJ.
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